Related Experiment Video

Updated: Nov 20, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

12.3K

Adjunctive Statin Therapy Reduces Mortality After Acute Hemorrhagic Stroke

Cheng-Kai Lin1,2, Po-Yuan Chen1,2, Yu-Ying Wu1,2

  • 1School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.

Risk Management and Healthcare Policy
|January 25, 2021
PubMed

Insights

Continuing statin therapy after acute intracerebral hemorrhage (ICH) in patients with dyslipidemia significantly reduces 10-year mortality. This finding supports the safety and efficacy of statins post-ICH.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Statin therapy is known to improve outcomes in ischemic stroke patients.
  • Evidence regarding the safety of statin use following intracerebral hemorrhage (ICH) is lacking.
  • This study investigates the impact of continuing statin treatment post-ICH.

Purpose of the Study:

  • To evaluate the effects of continued statin therapy in patients who have experienced an intracerebral hemorrhage.
  • To assess the safety and efficacy of statins in the ICH population.

Main Methods:

  • Retrospective analysis of data from Taiwan's National Health Insurance Research Database.
  • Comparison of outcomes between patients with and without statin exposure after ICH.
  • 10-year follow-up to assess hemorrhagic stroke recurrence and mortality.

Main Results:

  • The 10-year mortality rate was 32.73% in the statin group versus 42.77% in the non-statin group.
  • Statin therapy was associated with decreased mortality in acute ICH patients with dyslipidemia.

Conclusions:

  • Statin therapy demonstrated a significant reduction in the risk of 10-year mortality for patients with acute hemorrhagic stroke.
  • Continuing statins after ICH may be beneficial for reducing long-term mortality.
Abstract

Keywords:
hemorrhagic strokemortalitystatin

More Related Videos

Author Spotlight: Enhancing Coronary Artery Revascularization05:25

Author Spotlight: Enhancing Coronary Artery Revascularization

Published on: September 15, 2023

1.0K
A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.2K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
114
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
149
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
124